Clinical Trials Directory

Trials / Unknown

UnknownNCT03265730

Pediatric Antibiotic Associated Diarrhea

Incidence, Risk Factors and Severity of Pediatric Antibiotic Associated Diarrhea

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Hacettepe University · Academic / Other
Sex
All
Age
1 Month – 18 Years
Healthy volunteers
Not accepted

Summary

Diarrhea is one of the side effects of antibiotics. Antibiotic associated diarrhea can be encountered between two hours to two months after starting of antibiotics. The purpose of the study is to determine incidence,risk factors and severity of pediatric antibiotic associated diarrhea in Turkey.

Detailed description

Antibiotic associated diarrhea is a common adverse effect, occurring about 5-30% of patients either early during treatment or up to two months after the cessation of the treatment. The frequency differs according to the definition of diarrhea, the inciting antimicrobial agent and the host factors such geriatric age, immunosuppression, prolonged hospitalization. Almost all agents, especially the the ones acting on anaerobes may cause diarrhea. Clinical presentations range from mild diarrhea to fulminant pseudomembranous enterocolitis. In Turkey still data about antibiotic associated diarrhea is not enough. Incidence and the factors that effect severity are not known.

Conditions

Timeline

Start date
2016-08-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2017-08-29
Last updated
2017-11-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03265730. Inclusion in this directory is not an endorsement.

Pediatric Antibiotic Associated Diarrhea (NCT03265730) · Clinical Trials Directory